Abstract
Various human diseases are known to occur as a result of gene-environment interactions. Amongst such diseases, neurodegenerative Parkinson’s disease (PD) is a complex disorder in which genetics and exposure to toxins constitute the main determinants in the onset of the disease. Many studies have reported on a link between pesticide exposure and increased risk of PD, however the role of different classes of pesticides vis-à-vis Parkinsonism has not been well elucidated. We carried out the present study to explore the role of six groups of pesticides viz botanicals, herbicides, fungicides, organophosphates, carbamates and pyrethroids on PD and and associated neurotoxic effects. These pesticides were studied using transgenic Caenorhabditis elegans model expressing human alpha synuclein protein tagged with yellow fluorescent protein [NL5901; (Punc-54::alphasynuclein::YFP+unc-119)] in the body wall muscle. Amongst all the classes of pesticides examined, botanical rotenone showed severe effects on PD pathogenesis. It significantly increased alpha synuclein aggregation and oxidative stress. Furthermore, it reduced mitochondrial and lipid content in the worms. Pesticides from other classes were observed to exert marginal effects as compared to rotenone thus suggesting that there is a class or structure specific effect of environmental chemicals vis-à-vis Parkinsonism. Hence it may be deduced that all classes of toxicants do not induce similar effects on neurodegeneration and associated events.
Keywords: Parkinson disease, α-synuclein, pesticides, Caenorhabditis elegans.
CNS & Neurological Disorders - Drug Targets
Title:Environmental Toxicants as Extrinsic Epigenetic Factors for Parkinsonism: Studies Employing Transgenic C. elegans Model
Volume: 11 Issue: 8
Author(s): Pooja Jadiya and Aamir Nazir
Affiliation:
Keywords: Parkinson disease, α-synuclein, pesticides, Caenorhabditis elegans.
Abstract: Various human diseases are known to occur as a result of gene-environment interactions. Amongst such diseases, neurodegenerative Parkinson’s disease (PD) is a complex disorder in which genetics and exposure to toxins constitute the main determinants in the onset of the disease. Many studies have reported on a link between pesticide exposure and increased risk of PD, however the role of different classes of pesticides vis-à-vis Parkinsonism has not been well elucidated. We carried out the present study to explore the role of six groups of pesticides viz botanicals, herbicides, fungicides, organophosphates, carbamates and pyrethroids on PD and and associated neurotoxic effects. These pesticides were studied using transgenic Caenorhabditis elegans model expressing human alpha synuclein protein tagged with yellow fluorescent protein [NL5901; (Punc-54::alphasynuclein::YFP+unc-119)] in the body wall muscle. Amongst all the classes of pesticides examined, botanical rotenone showed severe effects on PD pathogenesis. It significantly increased alpha synuclein aggregation and oxidative stress. Furthermore, it reduced mitochondrial and lipid content in the worms. Pesticides from other classes were observed to exert marginal effects as compared to rotenone thus suggesting that there is a class or structure specific effect of environmental chemicals vis-à-vis Parkinsonism. Hence it may be deduced that all classes of toxicants do not induce similar effects on neurodegeneration and associated events.
Export Options
About this article
Cite this article as:
Jadiya Pooja and Nazir Aamir, Environmental Toxicants as Extrinsic Epigenetic Factors for Parkinsonism: Studies Employing Transgenic C. elegans Model, CNS & Neurological Disorders - Drug Targets 2012; 11 (8) . https://dx.doi.org/10.2174/1871527311211080006
DOI https://dx.doi.org/10.2174/1871527311211080006 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting
Current Pharmaceutical Design Recent Advances of Calcium Phosphate Nanoparticles for Controlled Drug Delivery
Mini-Reviews in Medicinal Chemistry Editorial (Thematic Issue: Stereoselective Synthesis and Applications of Compounds with N-O Bonds)
Current Organic Synthesis Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Biological Activities of Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry Current Metabolomic Methodologies & their Application to Thermal Stress
Current Metabolomics Molecular Pathophysiology of Renal Tubular Acidosis
Current Genomics Fetal Undernutrition and the Programming of Blood Pressure
Current Nutrition & Food Science NO Signaling Through cGMP in Renal Tissue Fibrosis and Beyond: Key Pathway and Novel Therapeutic Target
Current Medicinal Chemistry Antipsychotic Augmentation Strategies to Ameliorate Negative and Cognitive Symptoms in Schizophrenia; Implications for Future Research
Central Nervous System Agents in Medicinal Chemistry An Insight into the Therapeutic Potential of Major Coffee Components
Current Drug Metabolism Medical Treatment of Hirsutism in Women
Current Medicinal Chemistry Glucose Control and Use of Continuous Glucose Monitoring in the Intensive Care Unit: A Critical Review
Current Diabetes Reviews Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme
Current Medicinal Chemistry Phytoconstituents of <i>Lantana camara</i> L.: Rekindling Hope in the Cancer Treatment
Current Bioactive Compounds Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology
Current Drug Targets Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
Current Medicinal Chemistry Guanylation of Amines with Isonitriles in the Presence of Iodine
Letters in Organic Chemistry Pharmacokinetic-Pharmacodynamic Modeling of Antihypertensive Drugs: From Basic Research to Clinical Practice
Current Hypertension Reviews